Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Barriers toward epilepsy surgery. A survey among practicing neurologists.
Erba G, Moja L, Beghi E, Messina P, Pupillo E. Erba G, et al. Among authors: Pupillo E. Epilepsia. 2012 Jan;53(1):35-43. doi: 10.1111/j.1528-1167.2011.03282.x. Epub 2011 Oct 5. Epilepsia. 2012. PMID: 21973118
KEY FINDINGS: The neurologists gave responses characterized by extreme variability (i.e., wide response interquartile range) around intermediate scores. ...
KEY FINDINGS: The neurologists gave responses characterized by extreme variability (i.e., wide response interquartile range) around i …
The perceived burden of epilepsy: Impact on the quality of life of children and adolescents and their families.
Cianchetti C, Messina P, Pupillo E, Crichiutti G, Baglietto MG, Veggiotti P, Zamponi N, Casellato S, Margari L, Erba G, Beghi E; TASCA study group. Cianchetti C, et al. Among authors: Pupillo E. Seizure. 2015 Jan;24:93-101. doi: 10.1016/j.seizure.2014.09.003. Epub 2014 Sep 16. Seizure. 2015. PMID: 25264356 Clinical Trial.
Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy.
Beghi E, Messina P, Pupillo E, Crichiutti G, Baglietto MG, Veggiotti P, Zamponi N, Casellato S, Margari L, Cianchetti C; TASCA Study Group. Beghi E, et al. Among authors: Pupillo E. Epilepsy Res. 2012 Jun;100(1-2):142-51. doi: 10.1016/j.eplepsyres.2012.02.005. Epub 2012 Mar 3. Epilepsy Res. 2012. PMID: 22386633 Clinical Trial.
Non-self-sufficiency as a primary outcome measure in ALS trials.
Marin B, Bianchi E, Pupillo E, Lunetta C, Tremolizzo L, Logroscino G, Chiò A, Preux PM, Beghi E. Marin B, et al. Among authors: Pupillo E. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):77-84. doi: 10.3109/21678421.2015.1074704. Epub 2015 Oct 16. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26470831
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.
Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chiò A, Corbo M, Giannini F, Inghilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini L, Messina P, Mora G, Perini M, Quadrelli ML, Silani V, Simone IL, Tremolizzo L; Italian ALS Study Group. Beghi E, et al. Among authors: Pupillo E. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):397-405. doi: 10.3109/21678421.2013.764568. Epub 2013 Feb 19. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23421600 Clinical Trial.
Definite/probable ALS patients, 40-70 years of age, duration 6-24 months, self-sufficient (i.e. able to swallow, cut food/handle utensils, and walk), and with forced vital capacity (FVC) > 80% entered a pilot double-blind, placebo-controlled, parallel group trial and were followed for 48 weeks. ...Analysis was made in the intention-to-treat (ITT) and per-protocol (PP) population, completers and completers/compliers (i.e. taking > 75% of study drug). ...
Definite/probable ALS patients, 40-70 years of age, duration 6-24 months, self-sufficient (i.e. able to swallow, cut food/handle uten …
41 results
Jump to page
Feedback